Eric Rhodes

Eric Rhodes is a Chief Executive Officer at ERS Genomics. Eric has a strong background in gene regulation and gene editing. Prior to joining Horizon, he was Director of Business Development at Sigma-Aldrich Corp. where he helped Sigma in launching its nuclease based gene editing platform, and served for 10 years as Vice-President of Business Development and Alliance Management at Sangamo BioSciences.

At Sangamo he was responsible for securing and coordinating large target validation and technology licensing projects with over 25 of the top pharma and biotech companies in North America, Europe, and Asia.

Eric also has broad experience in growing small companies having participated in the successful launch of several start-ups in the San Francisco Bay Area.

Eric earned his degree in Microbiology and Immunology from UC Berkeley.

Eric Rhodes is the CEO at ERS Genomics, based in Europe. With a background in Biotechnology, Eric Rhodes has a rich history of leadership and innovation.Eric Rhodes studied BA Microbiology & Immunology at University of California Berkeley. Explore their detailed professional journey, key connections, and contributions to the industry on our platform.